YAP regulates PD-L1 expression in human NSCLC cells-Reference-Cited by-同舟云学术

YAP regulates PD-L1 expression in human NSCLC cells

Published:2017-12-09 Issue:70 Volume:8 Page:114576-114587
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Miao Jinbai¹²,Hsu Ping-Chih¹³,Yang Yi-Lin¹,Xu Zhidong¹,Dai Yuyuan¹,Wang Yucheng¹,Chan Geraldine¹⁴,Huang Zhen¹⁵,Hu Bin²,Li Hui²,Jablons David M.¹,You Liang¹

Affiliation:

1. Thoracic Oncology Laboratory, Department of Surgery, Comprehensive Cancer Center, University of California, San Francisco, CA, USA

2. Department of Thoracic Surgery, Beijing Chao-Yang Hospital, Affiliated with Capital Medical University, Beijing, People’s Republic of China

3. Department of Thoracic Medicine, Chang Gung Memorial Hospital, Linkou, Taoyuan, Taiwan

4. Class of 2020, Medical College of Wisconsin, Milwaukee, WI, USA

5. Department of Hepatobiliary Surgery, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 93 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of Hippo/YAP1 in cancer-associated fibroblasts: Literature review and future perspectives;Cancer Letters;2024-11

2. Targeted degradation of specific TEAD paralogs by small molecule degraders;Heliyon;2024-09

3. Discovery of YAP1/TAZ pathway inhibitors through phenotypic screening with potent anti-tumor activity via blockade of Rho-GTPase signaling;Cell Chemical Biology;2024-07

4. Targeting the Hippo pathway to prevent radioresistance brain metastases from the lung (Review);International Journal of Oncology;2024-05-17

5. TRAF6 enhances PD-L1 expression through YAP1-TFCP2 signaling in melanoma;Cancer Letters;2024-05